Mead Johnson Nutrition ( MJN) was upgraded at J.P. Morgan to overweight from neutral. $88 price target. Top-line growth should be valued more highly than the pending cost headwinds and the possibility of further Chinese government intervention, J.P. Morgan said. Public Service Enterprise ( PEG) was upgraded at Jefferies to buy from hold. The company is gaining more political support for its "energy strong" capital spending program, said Jefferies. Price target is $37. Quintiles ( Q) was initiated with a buy rating at UBS. Reflects scale, late-stage development exposure and supplemental growth from CSO, said UBS. Price target is $51. Steve Madden ( SHOO) was downgraded at Wedbush to neutral from outperform. Valuation call, based on a $55 price target, Wedbush said. Volcano ( VOLC) was upgraded at BMO Capital to outperform from market perform. $28 price target. Stock is attractively valued, and the company can achieve near-term earnings expectations, BMO Capital said.
Werner ( WERN) was downgraded at Keybanc to hold from buy. Company warned and is facing several issues, Keybanc said.
STOCK COMMENTS / EPS CHANGES
Aetna ( AET) numbers were raised at UBS. Estimates were raised as medical-claims trends should continue and CVH synergies could be better than expected, said UBS. Price target goes to $76. Celldex ( CLDX) price target was raised at Jefferies to $29 ahead of CDX-1127 PI trial data release. Packaging Corp of America ( PKG) numbers were reduced at Jefferies. Earnings estimates were adjusted lower to reflect less accretion from BZ acquisition, said Jefferies. Price target was reduced to $68. PerkinElmer ( PKI) numbers were raised at UBS. Estimates were raised as the company enters expanding markets and balances investment vs. growth, said UBS. Price target goes to $43. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.